Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Aurora Kinase B Market Growth 2022-2028

  • LP 4928591
  • 93 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Aurora Kinase B will have significant change from previous year. According to our (LP Information) latest study, the global Aurora Kinase B market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Aurora Kinase B market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Aurora Kinase B market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Aurora Kinase B market, reaching US$ million by the year 2028. As for the Europe Aurora Kinase B landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Aurora Kinase B players cover AbbVie Inc, Advenchen Laboratories LLC, Aeterna Zentaris Inc, and Amgen Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Aurora Kinase B market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

AZD-2811

CS-2164

Danusertib

Ilorasertib

NMI-900

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Anaplastic Large Cell Lymphoma

Kidney Cancer

Lung Cancer

Prostate Cancer

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

AbbVie Inc

Advenchen Laboratories LLC

Aeterna Zentaris Inc

Amgen Inc

AstraZeneca Plc

Chipscreen Biosciences Ltd

Cielo Therapeutics Inc

Sanofi

Sareum Holdings Plc

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Aurora Kinase B Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Aurora Kinase B by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Aurora Kinase B by Country/Region, 2017, 2022 & 2028

2.2 Aurora Kinase B Segment by Type

2.2.1 AZD-2811

2.2.2 CS-2164

2.2.3 Danusertib

2.2.4 Ilorasertib

2.2.5 NMI-900

2.2.6 Others

2.3 Aurora Kinase B Sales by Type

2.3.1 Global Aurora Kinase B Sales Market Share by Type (2017-2022)

2.3.2 Global Aurora Kinase B Revenue and Market Share by Type (2017-2022)

2.3.3 Global Aurora Kinase B Sale Price by Type (2017-2022)

2.4 Aurora Kinase B Segment by Application

2.4.1 Anaplastic Large Cell Lymphoma

2.4.2 Kidney Cancer

2.4.3 Lung Cancer

2.4.4 Prostate Cancer

2.4.5 Others

2.5 Aurora Kinase B Sales by Application

2.5.1 Global Aurora Kinase B Sale Market Share by Application (2017-2022)

2.5.2 Global Aurora Kinase B Revenue and Market Share by Application (2017-2022)

2.5.3 Global Aurora Kinase B Sale Price by Application (2017-2022)

3 Global Aurora Kinase B by Company

3.1 Global Aurora Kinase B Breakdown Data by Company

3.1.1 Global Aurora Kinase B Annual Sales by Company (2020-2022)

3.1.2 Global Aurora Kinase B Sales Market Share by Company (2020-2022)

3.2 Global Aurora Kinase B Annual Revenue by Company (2020-2022)

3.2.1 Global Aurora Kinase B Revenue by Company (2020-2022)

3.2.2 Global Aurora Kinase B Revenue Market Share by Company (2020-2022)

3.3 Global Aurora Kinase B Sale Price by Company

3.4 Key Manufacturers Aurora Kinase B Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Aurora Kinase B Product Location Distribution

3.4.2 Players Aurora Kinase B Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Aurora Kinase B by Geographic Region

4.1 World Historic Aurora Kinase B Market Size by Geographic Region (2017-2022)

4.1.1 Global Aurora Kinase B Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Aurora Kinase B Annual Revenue by Geographic Region

4.2 World Historic Aurora Kinase B Market Size by Country/Region (2017-2022)

4.2.1 Global Aurora Kinase B Annual Sales by Country/Region (2017-2022)

4.2.2 Global Aurora Kinase B Annual Revenue by Country/Region

4.3 Americas Aurora Kinase B Sales Growth

4.4 APAC Aurora Kinase B Sales Growth

4.5 Europe Aurora Kinase B Sales Growth

4.6 Middle East & Africa Aurora Kinase B Sales Growth

5 Americas

5.1 Americas Aurora Kinase B Sales by Country

5.1.1 Americas Aurora Kinase B Sales by Country (2017-2022)

5.1.2 Americas Aurora Kinase B Revenue by Country (2017-2022)

5.2 Americas Aurora Kinase B Sales by Type

5.3 Americas Aurora Kinase B Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Aurora Kinase B Sales by Region

6.1.1 APAC Aurora Kinase B Sales by Region (2017-2022)

6.1.2 APAC Aurora Kinase B Revenue by Region (2017-2022)

6.2 APAC Aurora Kinase B Sales by Type

6.3 APAC Aurora Kinase B Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Aurora Kinase B by Country

7.1.1 Europe Aurora Kinase B Sales by Country (2017-2022)

7.1.2 Europe Aurora Kinase B Revenue by Country (2017-2022)

7.2 Europe Aurora Kinase B Sales by Type

7.3 Europe Aurora Kinase B Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Aurora Kinase B by Country

8.1.1 Middle East & Africa Aurora Kinase B Sales by Country (2017-2022)

8.1.2 Middle East & Africa Aurora Kinase B Revenue by Country (2017-2022)

8.2 Middle East & Africa Aurora Kinase B Sales by Type

8.3 Middle East & Africa Aurora Kinase B Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Aurora Kinase B

10.3 Manufacturing Process Analysis of Aurora Kinase B

10.4 Industry Chain Structure of Aurora Kinase B

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Aurora Kinase B Distributors

11.3 Aurora Kinase B Customer

12 World Forecast Review for Aurora Kinase B by Geographic Region

12.1 Global Aurora Kinase B Market Size Forecast by Region

12.1.1 Global Aurora Kinase B Forecast by Region (2023-2028)

12.1.2 Global Aurora Kinase B Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Aurora Kinase B Forecast by Type

12.7 Global Aurora Kinase B Forecast by Application

13 Key Players Analysis

13.1 AbbVie Inc

13.1.1 AbbVie Inc Company Information

13.1.2 AbbVie Inc Aurora Kinase B Product Offered

13.1.3 AbbVie Inc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 AbbVie Inc Main Business Overview

13.1.5 AbbVie Inc Latest Developments

13.2 Advenchen Laboratories LLC

13.2.1 Advenchen Laboratories LLC Company Information

13.2.2 Advenchen Laboratories LLC Aurora Kinase B Product Offered

13.2.3 Advenchen Laboratories LLC Aurora Kinase B Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Advenchen Laboratories LLC Main Business Overview

13.2.5 Advenchen Laboratories LLC Latest Developments

13.3 Aeterna Zentaris Inc

13.3.1 Aeterna Zentaris Inc Company Information

13.3.2 Aeterna Zentaris Inc Aurora Kinase B Product Offered

13.3.3 Aeterna Zentaris Inc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Aeterna Zentaris Inc Main Business Overview

13.3.5 Aeterna Zentaris Inc Latest Developments

13.4 Amgen Inc

13.4.1 Amgen Inc Company Information

13.4.2 Amgen Inc Aurora Kinase B Product Offered

13.4.3 Amgen Inc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Amgen Inc Main Business Overview

13.4.5 Amgen Inc Latest Developments

13.5 AstraZeneca Plc

13.5.1 AstraZeneca Plc Company Information

13.5.2 AstraZeneca Plc Aurora Kinase B Product Offered

13.5.3 AstraZeneca Plc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 AstraZeneca Plc Main Business Overview

13.5.5 AstraZeneca Plc Latest Developments

13.6 Chipscreen Biosciences Ltd

13.6.1 Chipscreen Biosciences Ltd Company Information

13.6.2 Chipscreen Biosciences Ltd Aurora Kinase B Product Offered

13.6.3 Chipscreen Biosciences Ltd Aurora Kinase B Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Chipscreen Biosciences Ltd Main Business Overview

13.6.5 Chipscreen Biosciences Ltd Latest Developments

13.7 Cielo Therapeutics Inc

13.7.1 Cielo Therapeutics Inc Company Information

13.7.2 Cielo Therapeutics Inc Aurora Kinase B Product Offered

13.7.3 Cielo Therapeutics Inc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Cielo Therapeutics Inc Main Business Overview

13.7.5 Cielo Therapeutics Inc Latest Developments

13.8 Sanofi

13.8.1 Sanofi Company Information

13.8.2 Sanofi Aurora Kinase B Product Offered

13.8.3 Sanofi Aurora Kinase B Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Sanofi Main Business Overview

13.8.5 Sanofi Latest Developments

13.9 Sareum Holdings Plc

13.9.1 Sareum Holdings Plc Company Information

13.9.2 Sareum Holdings Plc Aurora Kinase B Product Offered

13.9.3 Sareum Holdings Plc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Sareum Holdings Plc Main Business Overview

13.9.5 Sareum Holdings Plc Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Aurora Kinase B Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Aurora Kinase B Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of AZD-2811

Table 4. Major Players of CS-2164

Table 5. Major Players of Danusertib

Table 6. Major Players of Ilorasertib

Table 7. Major Players of NMI-900

Table 8. Major Players of Others

Table 9. Global Aurora Kinase B Sales by Type (2017-2022) & (K Pcs)

Table 10. Global Aurora Kinase B Sales Market Share by Type (2017-2022)

Table 11. Global Aurora Kinase B Revenue by Type (2017-2022) & ($ million)

Table 12. Global Aurora Kinase B Revenue Market Share by Type (2017-2022)

Table 13. Global Aurora Kinase B Sale Price by Type (2017-2022) & (USD/Pcs)

Table 14. Global Aurora Kinase B Sales by Application (2017-2022) & (K Pcs)

Table 15. Global Aurora Kinase B Sales Market Share by Application (2017-2022)

Table 16. Global Aurora Kinase B Revenue by Application (2017-2022)

Table 17. Global Aurora Kinase B Revenue Market Share by Application (2017-2022)

Table 18. Global Aurora Kinase B Sale Price by Application (2017-2022) & (USD/Pcs)

Table 19. Global Aurora Kinase B Sales by Company (2020-2022) & (K Pcs)

Table 20. Global Aurora Kinase B Sales Market Share by Company (2020-2022)

Table 21. Global Aurora Kinase B Revenue by Company (2020-2022) ($ Millions)

Table 22. Global Aurora Kinase B Revenue Market Share by Company (2020-2022)

Table 23. Global Aurora Kinase B Sale Price by Company (2020-2022) & (USD/Pcs)

Table 24. Key Manufacturers Aurora Kinase B Producing Area Distribution and Sales Area

Table 25. Players Aurora Kinase B Products Offered

Table 26. Aurora Kinase B Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 27. New Products and Potential Entrants

Table 28. Mergers & Acquisitions, Expansion

Table 29. Global Aurora Kinase B Sales by Geographic Region (2017-2022) & (K Pcs)

Table 30. Global Aurora Kinase B Sales Market Share Geographic Region (2017-2022)

Table 31. Global Aurora Kinase B Revenue by Geographic Region (2017-2022) & ($ millions)

Table 32. Global Aurora Kinase B Revenue Market Share by Geographic Region (2017-2022)

Table 33. Global Aurora Kinase B Sales by Country/Region (2017-2022) & (K Pcs)

Table 34. Global Aurora Kinase B Sales Market Share by Country/Region (2017-2022)

Table 35. Global Aurora Kinase B Revenue by Country/Region (2017-2022) & ($ millions)

Table 36. Global Aurora Kinase B Revenue Market Share by Country/Region (2017-2022)

Table 37. Americas Aurora Kinase B Sales by Country (2017-2022) & (K Pcs)

Table 38. Americas Aurora Kinase B Sales Market Share by Country (2017-2022)

Table 39. Americas Aurora Kinase B Revenue by Country (2017-2022) & ($ Millions)

Table 40. Americas Aurora Kinase B Revenue Market Share by Country (2017-2022)

Table 41. Americas Aurora Kinase B Sales by Type (2017-2022) & (K Pcs)

Table 42. Americas Aurora Kinase B Sales Market Share by Type (2017-2022)

Table 43. Americas Aurora Kinase B Sales by Application (2017-2022) & (K Pcs)

Table 44. Americas Aurora Kinase B Sales Market Share by Application (2017-2022)

Table 45. APAC Aurora Kinase B Sales by Region (2017-2022) & (K Pcs)

Table 46. APAC Aurora Kinase B Sales Market Share by Region (2017-2022)

Table 47. APAC Aurora Kinase B Revenue by Region (2017-2022) & ($ Millions)

Table 48. APAC Aurora Kinase B Revenue Market Share by Region (2017-2022)

Table 49. APAC Aurora Kinase B Sales by Type (2017-2022) & (K Pcs)

Table 50. APAC Aurora Kinase B Sales Market Share by Type (2017-2022)

Table 51. APAC Aurora Kinase B Sales by Application (2017-2022) & (K Pcs)

Table 52. APAC Aurora Kinase B Sales Market Share by Application (2017-2022)

Table 53. Europe Aurora Kinase B Sales by Country (2017-2022) & (K Pcs)

Table 54. Europe Aurora Kinase B Sales Market Share by Country (2017-2022)

Table 55. Europe Aurora Kinase B Revenue by Country (2017-2022) & ($ Millions)

Table 56. Europe Aurora Kinase B Revenue Market Share by Country (2017-2022)

Table 57. Europe Aurora Kinase B Sales by Type (2017-2022) & (K Pcs)

Table 58. Europe Aurora Kinase B Sales Market Share by Type (2017-2022)

Table 59. Europe Aurora Kinase B Sales by Application (2017-2022) & (K Pcs)

Table 60. Europe Aurora Kinase B Sales Market Share by Application (2017-2022)

Table 61. Middle East & Africa Aurora Kinase B Sales by Country (2017-2022) & (K Pcs)

Table 62. Middle East & Africa Aurora Kinase B Sales Market Share by Country (2017-2022)

Table 63. Middle East & Africa Aurora Kinase B Revenue by Country (2017-2022) & ($ Millions)

Table 64. Middle East & Africa Aurora Kinase B Revenue Market Share by Country (2017-2022)

Table 65. Middle East & Africa Aurora Kinase B Sales by Type (2017-2022) & (K Pcs)

Table 66. Middle East & Africa Aurora Kinase B Sales Market Share by Type (2017-2022)

Table 67. Middle East & Africa Aurora Kinase B Sales by Application (2017-2022) & (K Pcs)

Table 68. Middle East & Africa Aurora Kinase B Sales Market Share by Application (2017-2022)

Table 69. Key Market Drivers & Growth Opportunities of Aurora Kinase B

Table 70. Key Market Challenges & Risks of Aurora Kinase B

Table 71. Key Industry Trends of Aurora Kinase B

Table 72. Aurora Kinase B Raw Material

Table 73. Key Suppliers of Raw Materials

Table 74. Aurora Kinase B Distributors List

Table 75. Aurora Kinase B Customer List

Table 76. Global Aurora Kinase B Sales Forecast by Region (2023-2028) & (K Pcs)

Table 77. Global Aurora Kinase B Sales Market Forecast by Region

Table 78. Global Aurora Kinase B Revenue Forecast by Region (2023-2028) & ($ millions)

Table 79. Global Aurora Kinase B Revenue Market Share Forecast by Region (2023-2028)

Table 80. Americas Aurora Kinase B Sales Forecast by Country (2023-2028) & (K Pcs)

Table 81. Americas Aurora Kinase B Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. APAC Aurora Kinase B Sales Forecast by Region (2023-2028) & (K Pcs)

Table 83. APAC Aurora Kinase B Revenue Forecast by Region (2023-2028) & ($ millions)

Table 84. Europe Aurora Kinase B Sales Forecast by Country (2023-2028) & (K Pcs)

Table 85. Europe Aurora Kinase B Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Middle East & Africa Aurora Kinase B Sales Forecast by Country (2023-2028) & (K Pcs)

Table 87. Middle East & Africa Aurora Kinase B Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Global Aurora Kinase B Sales Forecast by Type (2023-2028) & (K Pcs)

Table 89. Global Aurora Kinase B Sales Market Share Forecast by Type (2023-2028)

Table 90. Global Aurora Kinase B Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 91. Global Aurora Kinase B Revenue Market Share Forecast by Type (2023-2028)

Table 92. Global Aurora Kinase B Sales Forecast by Application (2023-2028) & (K Pcs)

Table 93. Global Aurora Kinase B Sales Market Share Forecast by Application (2023-2028)

Table 94. Global Aurora Kinase B Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 95. Global Aurora Kinase B Revenue Market Share Forecast by Application (2023-2028)

Table 96. AbbVie Inc Basic Information, Aurora Kinase B Manufacturing Base, Sales Area and Its Competitors

Table 97. AbbVie Inc Aurora Kinase B Product Offered

Table 98. AbbVie Inc Aurora Kinase B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 99. AbbVie Inc Main Business

Table 100. AbbVie Inc Latest Developments

Table 101. Advenchen Laboratories LLC Basic Information, Aurora Kinase B Manufacturing Base, Sales Area and Its Competitors

Table 102. Advenchen Laboratories LLC Aurora Kinase B Product Offered

Table 103. Advenchen Laboratories LLC Aurora Kinase B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 104. Advenchen Laboratories LLC Main Business

Table 105. Advenchen Laboratories LLC Latest Developments

Table 106. Aeterna Zentaris Inc Basic Information, Aurora Kinase B Manufacturing Base, Sales Area and Its Competitors

Table 107. Aeterna Zentaris Inc Aurora Kinase B Product Offered

Table 108. Aeterna Zentaris Inc Aurora Kinase B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 109. Aeterna Zentaris Inc Main Business

Table 110. Aeterna Zentaris Inc Latest Developments

Table 111. Amgen Inc Basic Information, Aurora Kinase B Manufacturing Base, Sales Area and Its Competitors

Table 112. Amgen Inc Aurora Kinase B Product Offered

Table 113. Amgen Inc Aurora Kinase B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 114. Amgen Inc Main Business

Table 115. Amgen Inc Latest Developments

Table 116. AstraZeneca Plc Basic Information, Aurora Kinase B Manufacturing Base, Sales Area and Its Competitors

Table 117. AstraZeneca Plc Aurora Kinase B Product Offered

Table 118. AstraZeneca Plc Aurora Kinase B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 119. AstraZeneca Plc Main Business

Table 120. AstraZeneca Plc Latest Developments

Table 121. Chipscreen Biosciences Ltd Basic Information, Aurora Kinase B Manufacturing Base, Sales Area and Its Competitors

Table 122. Chipscreen Biosciences Ltd Aurora Kinase B Product Offered

Table 123. Chipscreen Biosciences Ltd Aurora Kinase B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 124. Chipscreen Biosciences Ltd Main Business

Table 125. Chipscreen Biosciences Ltd Latest Developments

Table 126. Cielo Therapeutics Inc Basic Information, Aurora Kinase B Manufacturing Base, Sales Area and Its Competitors

Table 127. Cielo Therapeutics Inc Aurora Kinase B Product Offered

Table 128. Cielo Therapeutics Inc Aurora Kinase B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 129. Cielo Therapeutics Inc Main Business

Table 130. Cielo Therapeutics Inc Latest Developments

Table 131. Sanofi Basic Information, Aurora Kinase B Manufacturing Base, Sales Area and Its Competitors

Table 132. Sanofi Aurora Kinase B Product Offered

Table 133. Sanofi Aurora Kinase B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 134. Sanofi Main Business

Table 135. Sanofi Latest Developments

Table 136. Sareum Holdings Plc Basic Information, Aurora Kinase B Manufacturing Base, Sales Area and Its Competitors

Table 137. Sareum Holdings Plc Aurora Kinase B Product Offered

Table 138. Sareum Holdings Plc Aurora Kinase B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 139. Sareum Holdings Plc Main Business

Table 140. Sareum Holdings Plc Latest Developments

List of Figures

Figure 1. Picture of Aurora Kinase B

Figure 2. Aurora Kinase B Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Aurora Kinase B Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Aurora Kinase B Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Aurora Kinase B Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of AZD-2811

Figure 10. Product Picture of CS-2164

Figure 11. Product Picture of Danusertib

Figure 12. Product Picture of Ilorasertib

Figure 13. Product Picture of NMI-900

Figure 14. Product Picture of Others

Figure 15. Global Aurora Kinase B Sales Market Share by Type in 2021

Figure 16. Global Aurora Kinase B Revenue Market Share by Type (2017-2022)

Figure 17. Aurora Kinase B Consumed in Anaplastic Large Cell Lymphoma

Figure 18. Global Aurora Kinase B Market: Anaplastic Large Cell Lymphoma (2017-2022) & (K Pcs)

Figure 19. Aurora Kinase B Consumed in Kidney Cancer

Figure 20. Global Aurora Kinase B Market: Kidney Cancer (2017-2022) & (K Pcs)

Figure 21. Aurora Kinase B Consumed in Lung Cancer

Figure 22. Global Aurora Kinase B Market: Lung Cancer (2017-2022) & (K Pcs)

Figure 23. Aurora Kinase B Consumed in Prostate Cancer

Figure 24. Global Aurora Kinase B Market: Prostate Cancer (2017-2022) & (K Pcs)

Figure 25. Aurora Kinase B Consumed in Others

Figure 26. Global Aurora Kinase B Market: Others (2017-2022) & (K Pcs)

Figure 27. Global Aurora Kinase B Sales Market Share by Application (2017-2022)

Figure 28. Global Aurora Kinase B Revenue Market Share by Application in 2021

Figure 29. Aurora Kinase B Revenue Market by Company in 2021 ($ Million)

Figure 30. Global Aurora Kinase B Revenue Market Share by Company in 2021

Figure 31. Global Aurora Kinase B Sales Market Share by Geographic Region (2017-2022)

Figure 32. Global Aurora Kinase B Revenue Market Share by Geographic Region in 2021

Figure 33. Global Aurora Kinase B Sales Market Share by Region (2017-2022)

Figure 34. Global Aurora Kinase B Revenue Market Share by Country/Region in 2021

Figure 35. Americas Aurora Kinase B Sales 2017-2022 (K Pcs)

Figure 36. Americas Aurora Kinase B Revenue 2017-2022 ($ Millions)

Figure 37. APAC Aurora Kinase B Sales 2017-2022 (K Pcs)

Figure 38. APAC Aurora Kinase B Revenue 2017-2022 ($ Millions)

Figure 39. Europe Aurora Kinase B Sales 2017-2022 (K Pcs)

Figure 40. Europe Aurora Kinase B Revenue 2017-2022 ($ Millions)

Figure 41. Middle East & Africa Aurora Kinase B Sales 2017-2022 (K Pcs)

Figure 42. Middle East & Africa Aurora Kinase B Revenue 2017-2022 ($ Millions)

Figure 43. Americas Aurora Kinase B Sales Market Share by Country in 2021

Figure 44. Americas Aurora Kinase B Revenue Market Share by Country in 2021

Figure 45. United States Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)

Figure 46. Canada Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)

Figure 47. Mexico Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)

Figure 48. Brazil Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)

Figure 49. APAC Aurora Kinase B Sales Market Share by Region in 2021

Figure 50. APAC Aurora Kinase B Revenue Market Share by Regions in 2021

Figure 51. China Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)

Figure 52. Japan Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)

Figure 53. South Korea Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)

Figure 54. Southeast Asia Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)

Figure 55. India Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)

Figure 56. Australia Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)

Figure 57. Europe Aurora Kinase B Sales Market Share by Country in 2021

Figure 58. Europe Aurora Kinase B Revenue Market Share by Country in 2021

Figure 59. Germany Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)

Figure 60. France Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)

Figure 61. UK Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)

Figure 62. Italy Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)

Figure 63. Russia Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)

Figure 64. Middle East & Africa Aurora Kinase B Sales Market Share by Country in 2021

Figure 65. Middle East & Africa Aurora Kinase B Revenue Market Share by Country in 2021

Figure 66. Egypt Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)

Figure 67. South Africa Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)

Figure 68. Israel Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)

Figure 69. Turkey Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)

Figure 70. GCC Country Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)

Figure 71. Manufacturing Cost Structure Analysis of Aurora Kinase B in 2021

Figure 72. Manufacturing Process Analysis of Aurora Kinase B

Figure 73. Industry Chain Structure of Aurora Kinase B

Figure 74. Channels of Distribution

Figure 75. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390